GENNEX LABORATORIES
Back to Balance Sheet
|
GENNEX LABORATORIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹-0.23 Cr | ₹-0.14 Cr | ₹0.00 Cr | ₹0.15 Cr | ₹0.40 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of GENNEX LABORATORIES ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹-0.23 Cr |
Mar2023 | ₹-0.14 Cr |
Mar2022 | ₹0.00 Cr |
Mar2021 | ₹0.15 Cr |
Mar2020 | ₹0.40 Cr |
How is Deferred Tax Assets / Liabilities of GENNEX LABORATORIES Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹-0.23 Cr | Negative | |
Mar2023 | ₹-0.14 Cr | Negative | |
Mar2022 | ₹0.00 Cr | -98.04 | |
Mar2021 | ₹0.15 Cr | -61.65 | |
Mar2020 | ₹0.40 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of GENNEX LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GENNEX LABORATORIES | ₹286.5 Cr | -10.8% | -11.9% | -32.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,430.0 Cr | -3% | -8.7% | 4.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹145,410.0 Cr | -4.7% | -4.5% | 58.5% | Stock Analytics | |
CIPLA | ₹113,950.0 Cr | -4.3% | -3.2% | -3.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹99,682.3 Cr | -3% | -12.3% | 13.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹93,261.6 Cr | -3% | -6.5% | -12.7% | Stock Analytics |
GENNEX LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GENNEX LABORATORIES | -10.8% |
-11.9% |
-32.7% |
SENSEX | -3.4% |
-4.4% |
0.6% |
You may also like the below Video Courses